Roslin Technologies
Agri-tech company working to improve sustainable protein production across the livestock and aquaculture sectors.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 71.4x EV/Revenue -27.0x EV/EBITDA | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
| GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | (8 %) | (18 %) | (18 %) | (65 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (145 %) | (178 %) | (265 %) | (470 %) | (1357 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (148 %) | (137 %) | (271 %) | (422 %) | (1257 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Roslin Technologies is a Scottish-based life sciences company that specializes in the development and commercialization of animal cell lines for the cultivated meat industry. The company provides high-quality animal stem cells, including induced pluripotent stem cells (iPSCs), to producers of cultivated meat. This enables the scalable and sustainable production of meat directly from cells, without the need to raise and slaughter animals.
The company's primary clients are cultivated meat producers who use their cell lines as a foundational component for their products. Roslin Technologies operates in the burgeoning food and agriculture technology market, with a specific focus on the cellular agriculture segment. Its business model is centered on the development and sale of these specialized cell lines, and it also holds patents for its iPSC technology, which could provide licensing revenue streams. The company generates revenue by selling its cell lines to cultivated meat companies and through research and development collaborations.
Keywords: cultivated meat, cell lines, stem cells, iPSCs, biotechnology, sustainable protein, food technology, agritech, cellular agriculture, life sciences
